A BREAKTHROUGH NEW STUDY
SUGGESTS THAT INTRAVENOUS
VITAMIN MIGHT MAKE CANCER
TREATMENT MORE EFFECTIVE.
WHAT YOU NEED TO KNOW.
may help fight cancer
The idea that vitamin can benefit
cancer patients dates back, surprisingly,
to the 1950s. It got a boost in the 1970s
when Nobel laureate Linus Pauling, PhD,
advocated the use by cancer
patients, but his recommendation was
quickly followed by controversy.
In recent years, the use of vitamin
has gained a little momentum, thanks
to research at the National Institutes of
Health (NIH) and practicing physicians
who have been willing to buck the
big dollars and drugs of conventional
oncology. Now, a brand-new study has
shown that very large, regular doses of
vitamin can indeed help cancer patients.
To be fair, vitamin supplements will
help, but they have the distinct
anti-cancer effects of intravenous vitamin
(IVC). The body tightly regulates the
absorption of oral vitamin C, and the
excess is quickly excreted. So regardless
of how much a person takes, blood levels
of the vitamin will not increase to the
concentration needed to actually destroy
But when vitamin is administered
intravenously, to the tune of per
infusion, blood and tissue concentrations
increase dozens of times higher than
possible through oral consumption.
At those high levels, vitamin switches
BY JACK CHALLEM
from being an antioxidant to a pro-oxidant
in the cytoplasm of cells. Here, highdose vitamin stimulates production of
hydrogen peroxide, a potent generator
of free radicals that chip away at cancer
cells. The mechanism is similar to how
many conventional chemo drugs work, but
without the nasty side effects.
In the latest research, Jeanne Drisko,
MD, and Qi Chen, PhD, of the University
of Kansas Medical Center, studied 27
women with ovarian cancer, a disease
with a poor prognosis. All of the women
received the standard two-drug chemo
regimen for six months. Some of them,
however, also received 75 or 100 of IVC
twice weekly for a full year. The women
were tracked for five years.
According to article in the
journal Science Translational Medicine,
women receiving IVC experienced far
fewer side effects from the chemo drugs.
They also had significantly less damage to
the nervous system, bone marrow, liver,
pancreas and other organs, compared with
the women who received only chemo. And
they had less nausea and more
other words, better quality of life.
Did vitamin reduce the effect,
as most oncologists warn? Apparently
not. Women getting IVC actually went
an average of almost nine months longer
before their ovarian cancer became
active again, compared with those who
received only chemo. The researchers did
acknowledge, however, that the study was
too small to show a statistically reliable
increase in survival.
Drisko and her colleagues also conducted
studies on ovarian cancer in mice. They
showed that high-dose vitamin damaged
the DNA of cancer cells and robbed them of
the energy needed to proliferate, without
any negative effects on healthy cells.
The findings are consistent with a
growing body of research and
reports on the benefits of IVC. In one
such report, doctors showed that two